Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Uterine Cervical Dysplasia 12Keratosis, Actinic 11Melanoma 7Carcinoma, Basal Cell 7Glioma 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Glioblastoma 4Precancerous Conditions 3Hutchinson's Melanotic Freckle 3Vulvar Neoplasms 2Neoplasm Metastasis 2Hemangioma, Capillary 2Ependymoma 2Brain Neoplasms 2Astrocytoma 2Vaginal Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pigmentation Disorders 1Patient Satisfaction 1Papillomavirus Infections 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms 1

Interventions

Timolol 7Propranolol 6Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hemangioma, Capillary × Imiquimod × Clear all
NCT00979550 2018-03-22

The Effects of Aldara as an Adjunct to Laser Treatment

University of Kentucky

Phase 2 Terminated
7 enrolled 4 charts

Pigmentation Disorders, Hemangioma, Capillary

NCT00601016 2008-01-25

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

St. Justine's Hospital

Phase 2 Completed
18 enrolled

Hemangioma, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡